GAINESVILLE, Fla., January 20, 2026--neuropacsâ„¢ Corp., a leading innovator in AI-driven neurological diagnostics, announced today the successful raise of over $1.0 million in early-stage capital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results